GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
HEARTWARE (HTWR) [hlAlert]

Rating:
Buy HTWR
down 7.16 %

HEARTWARE (HTWR) rated Buy with price target $109 by CRT Capital

Posted on: Tuesday,  Nov 26, 2013  9:25 AM ET by CRT Capital

CRT Capital rated Buy HEARTWARE (NASDAQ: HTWR) on 11/26/2013, when the stock price was $93.05. Since
then, HEARTWARE has lost 7.17% as of 01/28/2016's recent price of $86.38.
If you would have followed this CRT Capital's recommendation on HTWR, you would have lost 7.16% of your investment in 793 days.

HeartWare International, Inc. (HeartWare), formerly HeartWare Limited, along with its subsidiaries, is a medical device company focused on developing small implantable pumps for the treatment of advanced heart failure. The Company?s product, the HeartWare Ventricular Assist System (the HeartWare System), includes a left ventricular assist device (LVAD), related accessories and surgical tools and is designed to provide circulatory support for patients with advanced heart failure. The core of the HeartWare System is a continuous flow blood pump, ventricular assist device (the HVAD Pump), a full-output device capable of pumping up to 10 liters of blood per minute. In January 2009, the HeartWare System received Conformite Europeene (CE) Marking, which allows for commercial sales in Europe and is the subject of an ongoing United States bridge-to-transplant clinical trial under an investigational device exemption (IDE) granted by the Food and Drug Administration of United States (FDA).

CRT Capital has consistently provided its clients with creative, idea-driven advice and solutions through targeted research and trading of High-Yield, Distressed, Convertible, and Emerging Market Debt Securities and Equities.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/26/2013 9:25 AM Buy
None
93.05 109.00
as of 12/13/2013
1 Week down  -4.36 %
1 Month down  -2.08 %
3 Months   
1 YTD down  -2.08 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy